Clinical Trial

Body Composition in Pediatric Patients With Thalassemia Major

Study acronym: BC-THAL
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To assess body composition (fat mass, lean mass, and bone mass) in pediatric patients with beta thalassemia major using appropriate tools (e.g.,Bioelectrical impedance analysis (BIA)). To evaluate the association between body composition and clinical parameters such as transfusion frequency, nutritional status, serum ferritin levels, endocrine complications.
Trial Details
NCT Number NCT07204015
Lead Sponsor Assiut University
Conditions Body Composition in Thalassemia Major
Enrollment 115 participants
Start Date 2025-10-01
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-02